San Diego, CA, United States of America

C Arjan Van Oeveren


 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: C Arjan Van Oeveren: Innovator in Granulocyte Colony-Stimulating Factor Receptor Research

Introduction

C Arjan Van Oeveren is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biomedical research, particularly in the area of granulocyte colony-stimulating factor receptor (GCFR). His work focuses on developing methods and compositions that can modulate the activity of this important receptor.

Latest Patents

C Arjan Van Oeveren holds 1 patent related to his research. The patent, titled "Methods and compositions associated with the granulocyte colony-stimulating factor receptor," includes various embodiments that describe compositions and methods for using or identifying compounds that can influence the activity of GCFR. These innovations have potential applications in treating disorders such as hematopoietic or neurological conditions.

Career Highlights

Currently, C Arjan Van Oeveren is associated with Ligand Pharmaceuticals, Inc., where he continues to advance his research. His work has been instrumental in exploring new therapeutic avenues that leverage the GCFR for medical treatments.

Collaborations

Throughout his career, C Arjan Van Oeveren has collaborated with esteemed colleagues, including Lin Zhi and Keith B Marschke. These partnerships have enriched his research and contributed to the development of innovative solutions in the biomedical field.

Conclusion

C Arjan Van Oeveren is a dedicated inventor whose work on granulocyte colony-stimulating factor receptor research holds promise for future medical advancements. His contributions to the field exemplify the impact of innovative thinking in addressing complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…